These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 29769376)

  • 21. The use of live attenuated bacteria as a delivery system for heterologous antigens.
    Garmory HS; Leary SE; Griffin KF; Williamson ED; Brown KA; Titball RW
    J Drug Target; 2003; 11(8-10):471-9. PubMed ID: 15203915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can a 'flawless' live vector vaccine strain be engineered?
    Galen JE; Levine MM
    Trends Microbiol; 2001 Aug; 9(8):372-6. PubMed ID: 11514219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection against genital tract Chlamydia trachomatis infection following intranasal immunization with a novel recombinant MOMP VS2/4 antigen.
    Hadad R; Marks E; Kalbina I; Schön K; Unemo M; Lycke N; Strid Å; Andersson S
    APMIS; 2016 Dec; 124(12):1078-1086. PubMed ID: 27859689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of Bordetella bronchiseptica and Bordetella pertussis as live vaccines and vectors for heterologous antigens.
    Stevenson A; Roberts M
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):121-8. PubMed ID: 12832115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Protection against human papillomavirus type 16-induced tumors in mice using non-genetically modified lactic acid bacteria displaying E7 antigen at its surface.
    Ribelles P; Benbouziane B; Langella P; Suárez JE; Bermúdez-Humarán LG
    Appl Microbiol Biotechnol; 2013 Feb; 97(3):1231-9. PubMed ID: 23212671
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recombinant lactobacillus expressing G protein of spring viremia of carp virus (SVCV) combined with ORF81 protein of koi herpesvirus (KHV): A promising way to induce protective immunity against SVCV and KHV infection in cyprinid fish via oral vaccination.
    Cui LC; Guan XT; Liu ZM; Tian CY; Xu YG
    Vaccine; 2015 Jun; 33(27):3092-9. PubMed ID: 25981489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant Lactobacillus johnsonii as a mucosal vaccine delivery vehicle.
    Scheppler L; Vogel M; Zuercher AW; Zuercher M; Germond JE; Miescher SM; Stadler BM
    Vaccine; 2002 Jul; 20(23-24):2913-20. PubMed ID: 12126902
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of mucosal immune responses against a heterologous antigen fused to filamentous hemagglutinin after intranasal immunization with recombinant Bordetella pertussis.
    Renauld-Mongénie G; Mielcarek N; Cornette J; Schacht AM; Capron A; Riveau G; Locht C
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7944-9. PubMed ID: 8755582
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perspective: edible vaccines--a concept coming of age.
    Mor TS; Gómez-Lim MA; Palmer KE
    Trends Microbiol; 1998 Nov; 6(11):449-53. PubMed ID: 9846363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Construction and immunological evaluation of dual cell surface display of HIV-1 gag and Salmonella enterica serovar Typhimurium FliC in Lactobacillus acidophilus for vaccine delivery.
    Kajikawa A; Zhang L; Long J; Nordone S; Stoeker L; LaVoy A; Bumgardner S; Klaenhammer T; Dean G
    Clin Vaccine Immunol; 2012 Sep; 19(9):1374-81. PubMed ID: 22761297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protection against tetanus toxin after intragastric administration of two recombinant lactic acid bacteria: impact of strain viability and in vivo persistence.
    Grangette C; Müller-Alouf H; Geoffroy M; Goudercourt D; Turneer M; Mercenier A
    Vaccine; 2002 Sep; 20(27-28):3304-9. PubMed ID: 12213400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunization with recombinant Lactobacillus casei strains producing K99, K88 fimbrial protein protects mice against enterotoxigenic Escherichia coli.
    Wen LJ; Hou XL; Wang GH; Yu LY; Wei XM; Liu JK; Liu Q; Wei CH
    Vaccine; 2012 May; 30(22):3339-49. PubMed ID: 21856357
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeted expression of anthrax protective antigen by Lactobacillus gasseri as an anthrax vaccine.
    Mohamadzadeh M; Durmaz E; Zadeh M; Pakanati KC; Gramarossa M; Cohran V; Klaenhammer TR
    Future Microbiol; 2010 Aug; 5(8):1289-96. PubMed ID: 20722604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antigen targeting to M cells for enhancing the efficacy of mucosal vaccines.
    Kim SH; Jang YS
    Exp Mol Med; 2014 Mar; 46(3):e85. PubMed ID: 24626171
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of live bacterial vaccine vectors for antigen delivery: potential and limitations.
    Medina E; Guzmán CA
    Vaccine; 2001 Feb; 19(13-14):1573-80. PubMed ID: 11166877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of live attenuated Bordetella pertussis strains expressing the universal influenza vaccine candidate M2e.
    Li R; Lim A; Ow ST; Phoon MC; Locht C; Chow VT; Alonso S
    Vaccine; 2011 Jul; 29(33):5502-11. PubMed ID: 21624415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A multivalent minigene vaccine, containing B-cell, cytotoxic T-lymphocyte, and Th epitopes from several microbes, induces appropriate responses in vivo and confers protection against more than one pathogen.
    An LL; Whitton JL
    J Virol; 1997 Mar; 71(3):2292-302. PubMed ID: 9032365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting mucosal dendritic cells with microbial antigens from probiotic lactic acid bacteria.
    Mohamadzadeh M; Duong T; Hoover T; Klaenhammer TR
    Expert Rev Vaccines; 2008 Mar; 7(2):163-74. PubMed ID: 18324887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sublingual immunization with an engineered Bacillus subtilis strain expressing tetanus toxin fragment C induces systemic and mucosal immune responses in piglets.
    Amuguni H; Lee S; Kerstein K; Brown D; Belitsky B; Herrmann J; Keusch G; Sonenshein A; Tzipori S
    Microbes Infect; 2012 May; 14(5):447-56. PubMed ID: 22198093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell-mediated and humoral immune responses after immunization of calves with a recombinant multiantigenic Mycobacterium avium subsp. paratuberculosis subunit vaccine at different ages.
    Thakur A; Aagaard C; Stockmarr A; Andersen P; Jungersen G
    Clin Vaccine Immunol; 2013 Apr; 20(4):551-8. PubMed ID: 23389934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.